An immunocytochemical assessment of 19 cases of cutaneous angiosarcoma

Histopathology

Volumn 28, Issue 3, 1996, Pages 235-240

  Orchard, G E ^a   Zelger, B ^b   Wilson Jones, E ^a   Russell Jones, R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Cutaneous angiosarcoma; Immunocytochemistry

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; ULEX EUROPAEUS AGGLUTININ;

ANGIOSARCOMA; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SKIN CANCER;

EID: 0029897804     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1996.d01-411.x     Document Type: Article

References (27)

1. Holden C, Spittle M, Wilson Jones E. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer 1987; 58; 1046-1057.
2. Maddox J, Evans H. Angiosarcoma of skin and soft tissue. A study of forty-four cases. Cancer 1981; 48; 1907-1921.
3. Hodgkinson D, Soule E, Woods J. Cutaneous angiosarcoma of the head and neck. Cancer 1979; 44; 1106-1113.
4. Wilson Jones E. Malignant angioendothelioma of the skin. Br. J. Dermatol. 1964; 76; 21-39.
5. Rosai J, Sumner H, Kostianovsky M, Perez-Mesa C. Angiosarcoma of the skin. A clinicopathologic and fine structural study. Human Pathol 1976; 7; 83-109.
6. Leader M, Collins M, Patel J, Henry K. Staining for factor VIII related antigen and Ulex europaeus agglutinin 1 (UEA1) in 230 tumours. An assessment of their specificity for angiosarcoma and Kaposi's sarcoma. Histopathology 1986; 10; 1153-1162.
7. Holden C, Spaull J, Das A, McKee P, Wilson Jones E. The histogenesis of angiosarcoma of the face and scalp; an immunohistochemical and ultrastructural study. Histopathology 1987; 11; 37-51.
8. Wilson A. Factor VIII related antigen staining by immunoperoxidase technic in smaller laboratories: A potential problem. Am. J. Clin. Pathol. 1984; 81; 117-120.
9. Schlingemann R, Dingjan G, Emeis J, Blok J, Warnaar S, Ruiter D. Monoclonal antibody PAL-E specific for endothelium. Lab. Invest. 1985; 52; 71-76.
10. Newton J, Spaull J, McGibbon D, Wilson Jones E. Malignant angiosarcoma of the scalp: a case report with immunohistochemical studies. Br. J. Dermatol. 1985; 112; 97-105.
11. Barsky S, Baker A, Siegal G. Use of anti-basement membrane antibodies to distinguish blood vessel capillaries from lymphatic capillaries. Am. J. Surg. Pathol. 1983; 7; 667-677.
12. Gray M, Rosenberg A, Dickersin R, Bhan A. Cytokeratin expression in epithelioid vascular neoplasms. Hum. Pathol. 1990; 21; 212-217.
13. Fletcher C, Beham A, Bekir S, Clarke M, Marley N. Epithelioid angiosarcoma of deep soft tissue: a distinctive tumor readily mistaken for an epithelial neoplasm. Am. J. Surg. Pathol. 1991; 15; 915-924.
14. Eusebi V, Carcangiu M, Dina R, Rosai J. Keratin-positive epithelioid angiosarcoma of thyroid. A report of four cases. Am. J. Surg. Pathol. 1990; 14; 737-747.
15. Wenig B, Abbondanzo S, Heffess C. Epithelioid angiosarcoma of the adrenal glands. A clinicopathologic study of nine cases with a discussion of the implications of Unding "Epithelial-specific" markers. Am. J. Surg. Pathol. 1994:. 18; 62-73.
16. Calonje E, Fletcher C, Wilson Jones E. Retiform hemangioendothelioma. A distinctive form of low-grade angiosarcoma delineated in a series of 15 cases. Am. J. Surg. Pathol. 1994; 18; 115-125.
17. Parums D, Cordell J, Mickleam K, Heryet A, Gatter K, Mason D. JC70: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J. Clin. Pathol. 1990; 43; 752-757.
18. Ramani P, Bradley N, Fletcher C. QBend/10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sections. Histopathology 1990; 17; 257-242.
19. Anthony P, Ramani P. Endothelial markers in malignant vascular tumours of the liver: Superiority of QBEND/10 over von Willebrand factor and Ulex europaeus agglutinin 1. J. Clin. Pathol. 1991; 44; 29-32.
20. Traweek T, Kandalaft P, Mehta P, Battifora H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am. J. Clin. Pathol. 1991; 96; 25-31.
21. Suster S, Wong T-Y. On the discriminatory value of anti-HPCA-1 (CD34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations. Am. J. Dermatopathol. 1994; 16; 355-363.
22. Russell Jones R, Orchard G, Zelger B, Wilson Jones E. Immunostaining for CD31 and CD34 in Kaposi's sarcoma. J. Clin. Path. 1995; 48; 1011-1016.
23. Weiss S, Nickoloff B. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am. J. Surg. Pathol. 1993; 17; 1039-1045.
24. Regezi J, Nickoloff B, Headington J. Oral submucosal dendrocytes: Factor XIIIa+ and CD34+ dendritic cell populations in normal tissue and fibrovascular lesions. J. Cut. Pathol. 1992; 19; 398-406.
25. Berger R, Albelda S, Berd D, Ioffreda M, Whitaker D, Murphy G. Expression of platelet endothelial cell adhesion molecule-1 (PECAM-1) during melanoma induced angiogenesis in vivo. J. Cut. Pathol. 1993; 20; 399-406.
26. Nickoloff B. PECAM-1 (CD31) is expressed on proliferating endothelial cells, stromal spindle-shaped cells and dermal dendrocytes in Kaposi's sarcoma. Arch. Dermatol. 1993; 129; 250-251.
27. Marrogi A, Hunt S, Santa Cruz D. Cutaneous epithelioid angiosarcoma. Am. J. Dermatopathol. 1990; 12; 350-356.